Business
Micron Biomedical Named to Fast Company’s 2026 List of World’s Most Innovative Companies for Addressing the Most Significant Bottlenecks in How Medicine is Made, Distributed and Administered
Recognition as second most innovative smaller company across all industries highlights transformative impact on public health, impactful industry collaborations, and a novel manufacturing approach that simplifies access to treatmentsALPHARETTA, Ga., March 30, 2026 (GLOBE NEWSWIRE) -- Micron Biomedical, a clinical stage company developing dissolvable, needle-free products that could replace injectable pharmaceuticals and vaccines, today announced it was named to the number two spot on Fast Compan
About this update from Micron Technology, Inc.
[{"type":"image","alt":"Micron Biomedical","displaySize":"","headline":null,"caption":"Micron Biomedical","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":139,"url":"https://media.zenfs.com/en/globenewswire.com/c68e42211550f0d9bf02ed33c3de025b"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/TbU_zAC_PHV818RYsFQbbg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE5NQ--/https://media.zenfs.com/en/globenewswire.com/c68e42211550f0d9bf02ed33c3de025b","width":300,"height":139}},"lazy":false},{"type":"text","content":"Recognition as second most innovative smaller company across all industries highlights transformative impact on public health, impactful industry collaborations, and a novel manufacturing approach that simplifies access to treatments","length":233,"tagName":"p"},{"type":"text","content":"ALPHARETTA, Ga., March 30, 2026 (GLOBE NEWSWIRE) -- Micron Biomedical, a clinical stage company developing dissolvable, needle-free products that could replace injectable pharmaceuticals and vaccines, today announced it was named to the number two spot on Fast Company’s prestigious list of the World’s Most Innovative Companies of 2026 in the "smaller companies” category.","length":378,"tagName":"p"},{"type":"text","content":"The recognition highlights implications of Micron Biomedical’s technology on overcoming cultural and logistical barriers to accessing vaccines, weight loss and diabetes management, pediatric and women’s health drugs, and other life-changing currently injected drugs. In the article, Fast Company calls out Micron’s ability to overcome high rates of needle phobia, clinician shortages in healthcare desserts, and cumbersome cold chain (refrigeration) requirements during storage and transport - as well as recent clinical, business and industry milestones that have poised Micron Biomedical to emerge as a leader in the space.","length":625,"tagName":"p"},{"type":"text","content":"“Removing the most significant bottlenecks in how vaccines and medicines are manufactured, distributed and administered requires not only transformative, cost-efficient solutions, but also strong public confidence in those approaches,” said Steven Damon, CEO of Micron Biomedical. “As a Fast Company Most Innovative Company, we are honored that our dissolvable therapeutic button technology continues to be recognized for aligning with patient pref...